Altamira Therapeutics drops on reverse stock split plan

Altamira Therapeutics

24/10/2022 15:13

** Shares of Altamira Therapeutics Ltd  CYTO.O  down ~25% to
$0.39 - set for their biggest daily pct decline since April
    ** Co announces 1-for-20 reverse stock split of its common
shares  urn:newsml:reuters.com:*:nGNX8rHf7n
    ** Reverse stock split primarily to regain compliance with
minimum bid price requirement for continued listing on the
Nasdaq - CYTO
    ** Reverse share split to reduce CYTO's number of common
shares outstanding from ~21.5 mln to ~1.1 mln
    ** Including session moves, stock is down ~79% YTD
 (Reporting by Raghav Mahobe)
 ((Raghav.Mahobe@thomsonreuters.com;))